Skip to content

Beverages and Societal Health

Sugar Sweetened Beverages And Cardiovascular Disease Risk

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01295671
Acronym
BASH III
Enrollment
203
Registered
2011-02-14
Start date
2011-02-28
Completion date
2015-11-30
Last updated
2018-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease, Obesity

Brief summary

The overall aim of the study is to compare the effects of three types of beverages - sugar-sweetened (SSB), artificially sweetened (ASB), and unsweetened (USB) - on cardiovascular disease (CVD) risk factors and body weight among young adults.

Detailed description

Consumption of sugar sweetened beverages (SSB) has been linked to obesity and, independent of body weight, risk for diabetes and cardiovascular disease. With rising public health awareness of these potential adverse effects, consumption of artificially sweetened beverages (ASB) has increased dramatically. These low-calorie products are marketed as diet, with the implication that they promote weight loss and improved health. However, there are no long-term experimental studies of ASB and body weight or any other health outcome. Several recent prospective observational studies have linked intake of ASB to increased risk of the metabolic syndrome, type 2 diabetes, and obesity. In the proposed clinical trial, 270 young adults who habitually consume SSB will be randomly assigned to one of three groups: 1) to continue consuming habitual levels of SSB; 2) to substitute ASB for SSB; or 3) to substitute unsweetened beverages for SSB. Each group will receive home delivery of the targeted beverage for 1 year, using methods that build upon previous successful work. Careful attention will be given to assuring treatment fidelity, equivalence of treatment intensity, and avoidance of experimental confounders. The primary study endpoint will be the ratio of serum triglyceride to HDL-cholesterol concentrations. Secondary endpoints will include changes in other cardiovascular disease risk factors, body weight, dietary quality, and taste preferences.

Interventions

BEHAVIORALProvision of beverages

Home delivery of specified beverage type

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Boston Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged 18 to 40 years * Consumption of at least 12 fluid ounces of sugar-sweetened beverage per day * Willingness to consume types of beverages consistent with group assignment * Body mass index (BMI) ranging from 18.5 - 40 kg/m2, and body weight ≤275 pounds * Access to a working telephone or cell phone

Exclusion criteria

* Intention to move away from the greater Boston area during the projected period of study enrollment (i.e., 1 year post-randomization) * Plans to be away from home for 5 weeks or longer during the study period (e.g., moving away from the greater Boston area during the summer) * Physician diagnosis of a major medical illness, eating disorder, or phenylketonuria (PKU) * Chronic use of any medication that may affect one or more study endpoints * Impaired fasting glucose (IFG, fasting blood glucose ≥110 mg/dL) * Current moderate or heavy smoker (\>10 cigarettes per day) * Another member of the family (i.e., first degree relative) or household participating in the study If female, * Pregnant in the past 12 months or planning to become pregnant during the study period * Lactating in the preceding 3 months * Change in birth control medication in previous 3 months or plans to change during the study period

Design outcomes

Primary

MeasureTime frame
Ratio of Serum Triglyceride to HDL-cholesterol Concentration (TG:HDLC)12 Month

Secondary

MeasureTime frameDescription
hsCRP12 MonthhsCRP
Fibrinogen12 MonthFibrinogen
Uric Acid12 MonthUric Acid
ALT12 MonthALT
LDL-C12 MonthLDL-C
Diastolic Blood Pressure12 MonthDiastolic Blood Pressure
Body Weight12 MonthBody Weight
Diet Quality: Sugar-Sweetened Beverage Consumption12 MonthDiet Quality: Sugar-Sweetened Beverage Consumption - servings per day
Preference for Sweet Taste12 MonthWe evaluated preference for sweet taste using ten solutions ranging in sucrose concentration (%m/v) from 0% (sample 1) to 18% (sample 10). After tasting each solution, participant reported the sample number corresponding to his or her overall favorite.
Systolic Blood Pressure12 MonthSystolic Blood Pressure

Countries

United States

Participant flow

Recruitment details

Subjects were recruited from the Boston metro area via multiple recruitment methods (i.e., print media, social media) from February 2011 through October 2014.

Pre-assignment details

3607 participants were initially telephone screened; 1462 were eligible after telephone screening; 407 were eligible after an Informational Visit; 222 provided informed consent; 19 withdrew or were found ineligible prior to completing baseline assessments. 203 participants completed baseline assessments and were randomized.

Participants by arm

ArmCount
Sugar-Sweetened Beverages
Sugar-sweetened beverages Provision of beverages: Home delivery of specified beverage type
67
Artificially-Sweetened Beverages
Artificially-sweetened beverages Provision of beverages: Home delivery of specified beverage type
67
Unsweetened Beverages
Unsweetened beverages Provision of beverages: Home delivery of specified beverage type
69
Total203

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyLost to Follow-up463
Overall StudyWithdrawal by Subject310

Baseline characteristics

CharacteristicSugar-Sweetened BeveragesArtificially-Sweetened BeveragesUnsweetened BeveragesTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
67 Participants67 Participants69 Participants203 Participants
Age, Continuous25.9 years
STANDARD_DEVIATION 5.1
26.7 years
STANDARD_DEVIATION 5.7
28.0 years
STANDARD_DEVIATION 6
26.9 years
STANDARD_DEVIATION 5.7
ALT14 U/L18 U/L16 U/L16 U/L
Body Weight75.5 kg
STANDARD_DEVIATION 15.6
76.8 kg
STANDARD_DEVIATION 16.7
77.5 kg
STANDARD_DEVIATION 16.1
76.6 kg
STANDARD_DEVIATION 16.1
Diastolic Blood Pressure67 mmHg
STANDARD_DEVIATION 8
67 mmHg
STANDARD_DEVIATION 8
68 mmHg
STANDARD_DEVIATION 7
67 mmHg
STANDARD_DEVIATION 8
Diet Quality: Sugar-Sweetened Beverage Consumption1.4 Servings per day
STANDARD_DEVIATION 1.1
1.5 Servings per day
STANDARD_DEVIATION 1.4
1.8 Servings per day
STANDARD_DEVIATION 1.3
1.6 Servings per day
STANDARD_DEVIATION 1.3
Fibrinogen241 mg/dL
STANDARD_DEVIATION 64
241 mg/dL
STANDARD_DEVIATION 74
250 mg/dL
STANDARD_DEVIATION 71
244 mg/dL
STANDARD_DEVIATION 70
hsCRP0.62 mg/L0.77 mg/L0.73 mg/L0.69 mg/L
LDL-C100 mg/dL
STANDARD_DEVIATION 27
102 mg/dL
STANDARD_DEVIATION 28
110 mg/dL
STANDARD_DEVIATION 33
104 mg/dL
STANDARD_DEVIATION 30
Preference for sweet taste6 Sample number6 Sample number7 Sample number6 Sample number
Ratio of Serum Triglyceride to HDL-cholesterol Concentration (TG:HDLC)1.37 ratio of Triglycerides-to-HDL1.30 ratio of Triglycerides-to-HDL1.51 ratio of Triglycerides-to-HDL1.37 ratio of Triglycerides-to-HDL
Region of Enrollment
United States
67 Participants67 Participants69 Participants203 Participants
Sex: Female, Male
Female
27 Participants40 Participants41 Participants108 Participants
Sex: Female, Male
Male
40 Participants27 Participants28 Participants95 Participants
Systolic Blood Pressure108 mmHg
STANDARD_DEVIATION 9
109 mmHg
STANDARD_DEVIATION 13
106 mmHg
STANDARD_DEVIATION 10
108 mmHg
STANDARD_DEVIATION 11
Uric Acid5.3 mg/dL
STANDARD_DEVIATION 1.3
5.2 mg/dL
STANDARD_DEVIATION 1.4
5.3 mg/dL
STANDARD_DEVIATION 1.5
5.3 mg/dL
STANDARD_DEVIATION 1.4

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 670 / 670 / 69
serious
Total, serious adverse events
2 / 671 / 670 / 69

Outcome results

Primary

Ratio of Serum Triglyceride to HDL-cholesterol Concentration (TG:HDLC)

Time frame: 12 Month

ArmMeasureValue (MEDIAN)
Sugar-Sweetened BeveragesRatio of Serum Triglyceride to HDL-cholesterol Concentration (TG:HDLC)1.46 ratio of Triglycerides-to-HDL
Artificially-sweetened BeveragesRatio of Serum Triglyceride to HDL-cholesterol Concentration (TG:HDLC)1.19 ratio of Triglycerides-to-HDL
Unsweetened BeveragesRatio of Serum Triglyceride to HDL-cholesterol Concentration (TG:HDLC)1.45 ratio of Triglycerides-to-HDL
Secondary

ALT

ALT

Time frame: 12 Month

ArmMeasureValue (MEDIAN)
Sugar-Sweetened BeveragesALT16 U/L
Artificially-sweetened BeveragesALT16 U/L
Unsweetened BeveragesALT17 U/L
Secondary

Body Weight

Body Weight

Time frame: 12 Month

Population: Data missing for 1 subject in ASB group.

ArmMeasureValue (MEAN)Dispersion
Sugar-Sweetened BeveragesBody Weight78.0 kgStandard Deviation 17.4
Artificially-sweetened BeveragesBody Weight76.8 kgStandard Deviation 17.2
Unsweetened BeveragesBody Weight78.3 kgStandard Deviation 17.1
Secondary

Diastolic Blood Pressure

Diastolic Blood Pressure

Time frame: 12 Month

ArmMeasureValue (MEAN)Dispersion
Sugar-Sweetened BeveragesDiastolic Blood Pressure68 mmHgStandard Deviation 9
Artificially-sweetened BeveragesDiastolic Blood Pressure67 mmHgStandard Deviation 8
Unsweetened BeveragesDiastolic Blood Pressure67 mmHgStandard Deviation 8
Secondary

Diet Quality: Sugar-Sweetened Beverage Consumption

Diet Quality: Sugar-Sweetened Beverage Consumption - servings per day

Time frame: 12 Month

Population: Data missing for 1 subject in USB group.

ArmMeasureValue (MEAN)Dispersion
Sugar-Sweetened BeveragesDiet Quality: Sugar-Sweetened Beverage Consumption2.5 Servings per dayStandard Deviation 1.8
Artificially-sweetened BeveragesDiet Quality: Sugar-Sweetened Beverage Consumption0.1 Servings per dayStandard Deviation 0.3
Unsweetened BeveragesDiet Quality: Sugar-Sweetened Beverage Consumption0.2 Servings per dayStandard Deviation 2.5
Secondary

Fibrinogen

Fibrinogen

Time frame: 12 Month

ArmMeasureValue (MEAN)Dispersion
Sugar-Sweetened BeveragesFibrinogen244 mg/dLStandard Deviation 49
Artificially-sweetened BeveragesFibrinogen248 mg/dLStandard Deviation 62
Unsweetened BeveragesFibrinogen236 mg/dLStandard Deviation 73
Secondary

hsCRP

hsCRP

Time frame: 12 Month

ArmMeasureValue (MEDIAN)
Sugar-Sweetened BeverageshsCRP0.86 mg/L
Artificially-sweetened BeverageshsCRP0.64 mg/L
Unsweetened BeverageshsCRP0.85 mg/L
Secondary

LDL-C

LDL-C

Time frame: 12 Month

ArmMeasureValue (MEAN)Dispersion
Sugar-Sweetened BeveragesLDL-C103 mg/dLStandard Deviation 31
Artificially-sweetened BeveragesLDL-C104 mg/dLStandard Deviation 30
Unsweetened BeveragesLDL-C109 mg/dLStandard Deviation 29
Secondary

Preference for Sweet Taste

We evaluated preference for sweet taste using ten solutions ranging in sucrose concentration (%m/v) from 0% (sample 1) to 18% (sample 10). After tasting each solution, participant reported the sample number corresponding to his or her overall favorite.

Time frame: 12 Month

Population: Data missing for 1 subject in SSB group.

ArmMeasureValue (MEDIAN)
Sugar-Sweetened BeveragesPreference for Sweet Taste6 Sample number
Artificially-sweetened BeveragesPreference for Sweet Taste6 Sample number
Unsweetened BeveragesPreference for Sweet Taste5 Sample number
Secondary

Systolic Blood Pressure

Systolic Blood Pressure

Time frame: 12 Month

ArmMeasureValue (MEAN)Dispersion
Sugar-Sweetened BeveragesSystolic Blood Pressure109 mmHgStandard Deviation 10
Artificially-sweetened BeveragesSystolic Blood Pressure107 mmHgStandard Deviation 11
Unsweetened BeveragesSystolic Blood Pressure106 mmHgStandard Deviation 9
Secondary

Uric Acid

Uric Acid

Time frame: 12 Month

ArmMeasureValue (MEAN)Dispersion
Sugar-Sweetened BeveragesUric Acid5.2 mg/dLStandard Deviation 1.3
Artificially-sweetened BeveragesUric Acid5.1 mg/dLStandard Deviation 1.4
Unsweetened BeveragesUric Acid5.4 mg/dLStandard Deviation 1.5

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026